J R Evans1, A E Fletcher, R P L Wormald. 1. Department of Epidemiology and International Eye Health, Institute of Ophthalmology, London, UK.
Abstract
BACKGROUND:Visual impairment and blindness are common in older people in Britain. It is important to know the causes of visual impairment to develop health service and research priorities. The authors aimed to identify the causes of visual impairment in people aged 75 years and older in Britain. METHODS: In the MRC Trial of the Assessment and Management of Older People in the Community, trial nurses tested visual acuity in everyone aged 75 years and older in 53 general practices. For all visually impaired patients in 49 of the 53 medical practices, data regarding the cause of vision loss were extracted from the general practice medical notes. Additional follow up questionnaires were also sent to the hospital ophthalmologist to confirm the cause of vision loss. Visual impairment was defined as a binocular acuity of less than 6/18. RESULTS: There were 1742 (12.5%) people visually impaired in the 49 participating practices. Of these, 450 (26%) achieved a pinhole visual acuity in either eye of 6/18 or better. In these people, the principal reason for visual loss was considered to be refractive error. The cause of visual loss was available for 976 (76%) of the remaining 1292 visually impaired people identified. The main cause of visual loss was age related macular degeneration (AMD); 52.9% (95% confidence interval 49.2 to 56.5) of people had AMD as a main or contributory cause. This was followed by cataract (35.9%), glaucoma (11.6%), myopic degeneration (4.2%), and diabetic eye disease (3.4%). CONCLUSIONS: A substantial proportion of visual impairment in our sample of older people in Britain can be attributed to remediable causes-refractive error and cataract. There is considerable potential for visual rehabilitation in this age group. For the large proportion with macular degeneration, low vision services will be important.
RCT Entities:
BACKGROUND:Visual impairment and blindness are common in older people in Britain. It is important to know the causes of visual impairment to develop health service and research priorities. The authors aimed to identify the causes of visual impairment in people aged 75 years and older in Britain. METHODS: In the MRC Trial of the Assessment and Management of Older People in the Community, trial nurses tested visual acuity in everyone aged 75 years and older in 53 general practices. For all visually impaired patients in 49 of the 53 medical practices, data regarding the cause of vision loss were extracted from the general practice medical notes. Additional follow up questionnaires were also sent to the hospital ophthalmologist to confirm the cause of vision loss. Visual impairment was defined as a binocular acuity of less than 6/18. RESULTS: There were 1742 (12.5%) people visually impaired in the 49 participating practices. Of these, 450 (26%) achieved a pinhole visual acuity in either eye of 6/18 or better. In these people, the principal reason for visual loss was considered to be refractive error. The cause of visual loss was available for 976 (76%) of the remaining 1292 visually impaired people identified. The main cause of visual loss was age related macular degeneration (AMD); 52.9% (95% confidence interval 49.2 to 56.5) of people had AMD as a main or contributory cause. This was followed by cataract (35.9%), glaucoma (11.6%), myopic degeneration (4.2%), and diabetic eye disease (3.4%). CONCLUSIONS: A substantial proportion of visual impairment in our sample of older people in Britain can be attributed to remediable causes-refractive error and cataract. There is considerable potential for visual rehabilitation in this age group. For the large proportion with macular degeneration, low vision services will be important.
Authors: J C van der Pols; C J Bates; P V McGraw; J R Thompson; M Reacher; A Prentice; S Finch Journal: Br J Ophthalmol Date: 2000-02 Impact factor: 4.638
Authors: J R Evans; A E Fletcher; R P L Wormald; E Siu-Woon Ng; S Stirling; L Smeeth; E Breeze; C J Bulpitt; M Nunes; D Jones; A Tulloch Journal: Br J Ophthalmol Date: 2002-07 Impact factor: 4.638
Authors: Pirro G Hysi; Terri L Young; David A Mackey; Toby Andrew; Alberto Fernández-Medarde; Abbas M Solouki; Alex W Hewitt; Stuart Macgregor; Johannes R Vingerling; Yi-Ju Li; M Kamran Ikram; Lee Yiu Fai; Pak C Sham; Lara Manyes; Angel Porteros; Margarida C Lopes; Francis Carbonaro; Samantha J Fahy; Nicholas G Martin; Cornelia M van Duijn; Timothy D Spector; Jugnoo S Rahi; Eugenio Santos; Caroline C W Klaver; Christopher J Hammond Journal: Nat Genet Date: 2010-09-12 Impact factor: 38.330
Authors: Abu Emran Bashar; Andrew Metcalfe; Anat Yanai; Christopher Laver; Urs O Häfeli; Cheryl Y Gregory-Evans; Orson L Moritz; Joanne A Matsubara; Kevin Gregory-Evans Journal: IEEE Trans Magn Date: 2013-01-01 Impact factor: 1.700
Authors: Justin C Sherwin; Anthony P Khawaja; David Broadway; Robert Luben; Shabina Hayat; Nichola Dalzell; Nicholas J Wareham; Kay-Tee Khaw; Paul J Foster Journal: Br J Ophthalmol Date: 2012-04-25 Impact factor: 4.638
Authors: Ulrich F O Luhmann; Scott Robbie; Peter M G Munro; Susie E Barker; Yanai Duran; Vy Luong; Frederick W Fitzke; James W B Bainbridge; Robin R Ali; Robert E MacLaren Journal: Invest Ophthalmol Vis Sci Date: 2009-07-02 Impact factor: 4.799